ArticleResuscitation plus2025
Association of human immunodeficiency virus with acute myocardial infarction and presumed sudden cardiac death.
Article in Resuscitation plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While extensive evidence linking human immunodeficiency virus (HIV) infection to acute myocardial infarction (AMI), several studies have also suggested an association between HIV and presumed sudden cardiac death (PSCD). Our objective was to evaluate the association between HIV and PSCD compared to AMI. Understanding whether HIV confers differential risks for distinct cardiovascular outcomes is essential to guide prevention strategies and risk stratification in this population. Methods: The study design was a case-control study. We combined data from the large prospective population-based Paris Sudden Death Expertise Center Registry on PSCD and from the French National Health Insurance (SNDS) database. The SNDS database contains comprehensive data on all reimbursements for health-related expenditures and detailed medical information on all admissions to French public and private hospitals. In this study, adult patients with PSCD that occurred between 2011 and 2020 in Paris and the 3 adjacent departments were matched with AMI controls. We identified HIV patients in the 2 populations. We used a logistic regression to estimate the association between HIV and PSCD compared to HIV and AMI, adjusted for confounders. Results: In this study, 22,510 PSCD patients (60% men, age 71 (17) years) were matched with 22,510 AMI controls (60% men, age 72 (17) years). Among them, 245 (1%) and 104 (1%) had a positive HIV status preceding PSCD and AMI respectively. The odds of PSCD was 97% higher than the odds of AMI in HIV patients (adjusted odds-ratio, 1.97; 95% confidence interval: 1.55-2.49) Conclusions: Our findings, based on big data analysis, strongly suggest a significant association between HIV status and PSCD, also among patients without a history of AMI. The underlying mechanisms still remain incompletely defined and further studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.